from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1867/-

LFCtreatmentdescriptionclass of inhibitor

0.451

Amikacinug/mL Amikacintranslation

1.132

Cap5-10ug/mL Capreomycintranslation

1.089

Rox10-50 ug/mL Roxithromycintranslation

0.493

SM2-5 ug/mL Streptomycintranslation

2.397

Tet5-10 ug/mL Tetracyclinetranslation

1.228

Rif0.2-5ug/mL Rifampicintranscription

0.570

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.728

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.059

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.539

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.040

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.446

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.107

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.226

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.952

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.445

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-2.169

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.609

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.478

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.235

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.249

Nigericin50 uM Nigericinrespiration

0.932

TRC10-150 ug/mL Triclosanrespiration

1.286

TRZ10-25 ug/mL Thioridazinerespiration

-1.869

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.998

menadione6-10 ug/mL Menadionerespiration

-0.288

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.755

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.415

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.110

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.385

NRP_1Non-replicating persistence stage 1dosRassociated

0.370

Amp0.2mg/mL AmpicillincellWall

0.131

Cephalexin20-100 ug/mL CephalexincellWall

-0.448

Cerulenin0.32-5 ug/mL CerulenincellWall

0.398

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.593

EMB10-20 ug/mL EthambutolcellWall

1.267

Eta12-40 ug/mL EthionamidecellWall

0.965

INH0.2-0.4 ug/mL IsoniazidcellWall

0.770

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.193

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.153

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.003

BZA0.12 mg/mL BenzamidearomaticAmides

0.095

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.328

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.060

H2O24 mM hydrogen peroxideDNAdamaging

-0.160

Levo10 ug/mL LevofloxacinDNAdamaging

-0.734

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.782

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.106

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.199

UVUV-irradiationDNAdamaging

-0.454

ARP41-4 ug/mL Antitubercular compound ARP4?

0.183

Antimycin12.5-50 ug/mL Antimycin A?

-0.005

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.485

PA_110-50 ug/mL Antitubercular compound PA-1?

0.280

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.090

PA8240.2-2 ug/mL PA-824?

-0.977

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.469

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.048

Verapamil50 uM Verapamil?

-0.195

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.528

methoxatin10-20 ug/mL Methoxatin?